First-line antibiotic for odontogenic infections in non-allergic patients?

Study for the Manor Preboards Module 2 Test. Use flashcards and multiple choice questions that include hints and explanations. Prepare thoroughly for your exam!

Multiple Choice

First-line antibiotic for odontogenic infections in non-allergic patients?

Explanation:
Odontogenic infections are caused by a mix of common oral bacteria, including viridans streptococci and anaerobes. The best first-line antibiotic should reach reliable levels in the inflamed dental tissues and cover these organisms. Amoxicillin has excellent oral bioavailability, so it produces steady and effective concentrations in serum and tissues, including the periapical area. This makes it a dependable empiric choice for lifting the infection early and effectively. It also targets the typical oral pathogens, providing good coverage without needing complex dosing, which helps patients complete the course. Penicillin VK is a valid alternative, but amoxicillin’s pharmacokinetic advantages—better absorption and convenient dosing—often make it the preferred first-line option in non-allergic patients. The other options don’t offer the same reliable coverage of the common anaerobic and aerobic oral bacteria or have less favorable pharmacokinetic profiles for this scenario.

Odontogenic infections are caused by a mix of common oral bacteria, including viridans streptococci and anaerobes. The best first-line antibiotic should reach reliable levels in the inflamed dental tissues and cover these organisms. Amoxicillin has excellent oral bioavailability, so it produces steady and effective concentrations in serum and tissues, including the periapical area. This makes it a dependable empiric choice for lifting the infection early and effectively. It also targets the typical oral pathogens, providing good coverage without needing complex dosing, which helps patients complete the course. Penicillin VK is a valid alternative, but amoxicillin’s pharmacokinetic advantages—better absorption and convenient dosing—often make it the preferred first-line option in non-allergic patients. The other options don’t offer the same reliable coverage of the common anaerobic and aerobic oral bacteria or have less favorable pharmacokinetic profiles for this scenario.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy